Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
Restricted accessReview articleFirst published online March, 2018
Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
Frailty is increasingly seen among patients with acute cardiovascular disease. A combination of an ageing population, improved disease survival, treatable long-term conditions as well as a greater recognition of the syndrome has accelerated the prevalence of frailty in the modern world. Yet, this has not been matched by an expansion of research. National and international bodies have identified acute cardiovascular disease in the frail as a priority area for care and an entity that requires careful clinical decisions, but there remains a paucity of guidance on treatment efficacy and safety, and how to manage this complex group. This position paper from the Acute Cardiovascular Care Association presents the latest evidence about frailty and the management of frail patients with acute cardiovascular disease, and suggests avenues for future research.
SinghMStewartRWhiteH.Importance of frailty in patients with cardiovascular disease. Eur Heart J2014; 35: 1726–1731.
2.
BuckinxFRollandYReginsterJ-Yet al. Burden of frailty in the elderly population: Perspectives for a public health challenge. Arch Public Health2015; 73: 19.
3.
BellSPSarafAA.Epidemiology of multimorbidity in older adults with cardiovascular disease. Clin Geriatr Med2016; 32: 215–226.
4.
MorleyJEVellasBvan KanGAet al. Frailty consensus: A call to action. J Am Med Dir Assoc2013; 14: 392–397.
5.
RichMWChyunDASkolnickAHet al. Knowledge gaps in cardiovascular care of the older adult population: A scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Am Coll Cardiol2016; 67: 2419–2440.
6.
McDermidRCStelfoxHTBagshawSM.Frailty in the critically ill: A novel concept. Crit Care2011; 15(1): 301.
7.
CleggAYoungJIliffeSet al. Frailty in elderly people. Lancet2013; 381: 752–762.
8.
FriedLPTangenCMWalstonJet al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001; 56: M146–M156.
9.
RockwoodKSongXMacKnightCet al. A global clinical measure of fitness and frailty in elderly people. CMAJ2005; 173: 489–495.
10.
de VriesNMStaalJBvan RavensbergCDet al. Outcome instruments to measure frailty: A systematic review. Ageing Res Rev2011; 10: 104–114.
11.
SuttonJLGouldRLDaleySet al. Psychometric properties of multicomponent tools designed to assess frailty in older adults: A systematic review. BMC Geriatr2016; 16: 55.
12.
EelesEMWhiteSVO’MahonySMet al. The impact of frailty and delirium on mortality in older inpatients. Age Aging2012; 41: 412–416.
13.
BagshawSMMajumdarSRRolfsonDBet al. A prospective multicenter cohort study of frailty in younger critically ill patients. Crit Care2016; 20: 175.
14.
EkerstadNSwahnEJanzonMet al. Frailty is independently associated with 1-year mortality for elderly patients with non-ST-segment elevation myocardial infarction. Eur J Prev Cardiol2014; 21: 1216–1224.
15.
IllsleyDACleggDA.Assessment of frailty in the inpatient setting. Br J Hosp Med2016; 77: 29–32.
16.
TurnerGCleggA.Best practice guidelines for the management of frailty: A British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Aging2014; 43: 744–747.
17.
AfilaloJAlexanderKPMackMJet al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol2014; 63: 747–762.
18.
KulmalaJNykanenIHartikainenS.Frailty as a predictor of all-cause mortality in older men and women. Geriatr Gerontol Int2014; 14: 899–905.
BagshawSMMcDermidRC.The role of frailty in outcomes from critical illness. Curr Opin Crit Care2013; 19: 496–503.
21.
ButaBJWalstonJDGodinoJGet al. Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev2016; 26: 53–61.
22.
HoganDBFreiheitEAStrainLAet al. Comparing frailty measures in their ability to predict adverse outcome among older residents of assisted living. BMC Geriatr2012; 12: 56.
23.
HoogendijkEOvan der HorstHEDeegDJHet al. The identification of frail older adults in primary care: Comparing the accuracy of five simple instruments. Age Aging2013; 42: 262–265.
24.
FriedLPTangenCMWalstonJet al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001; 56(3); M146–156.
25.
van IerselMBMunnekeMEsselinkRAet al. Gait velocity and the Timed-Up-and-Go test were sensitive to changes in mobility in frail elderly patients. J Clin Epidemiol2008; 61: 186–191.
26.
MitnitskiABGrahamJEMogilnerAJet al. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr2002; 2: 1.
27.
RockwoodKSongXMacKnightCet al. A global clinical measure of fitness and frailty in elderly people. CMAJ2005; 173(5): 489-495.
28.
CleggABatesCYoungJet al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Aging2016; 45: 353–360.
29.
EllisGWhiteheadMAO’NeillDet al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev2011; 7: Cd006211.
30.
RolfsonDBMajumdarSRTsuyukiRTet al. Validity and reliability of the Edmonton Frail Scale. Age Aging2006; 35: 526–529.
31.
PilottoAFerrucciLFranceschiMet al. Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res2008; 11: 151–161.
32.
Rodriguez-PascualCVilches-MoragaAParedes-GalanEet al. Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure. Am Heart J2012; 164: 756–762.
CollardRMBoterHSchoeversRAet al. Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc2012; 60: 1487–1492.
35.
Santos-EggimannBCuenoudPSpagnoliJet al. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci2009; 64: 675–681.
36.
XueQL.The frailty syndrome: Definition and natural history. Clin Geriatr Med2011; 27: 1–15.
37.
KojimaG.Prevalence of frailty in nursing homes: A systematic review and meta-analysis. J Am Med Dir Assoc2015; 16: 940–945.
38.
NewmanABGottdienerJSMcBurnieMAet al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci2001; 56: M158–M166.
39.
SinghMRihalCLennonRet al. Correlates of frailty in patients with coronary heart disease undergoing percutaneous coronary interventions. Circulation2007; 115: E556.
40.
SinghMRihalCSLennonRJet al. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization. Circ Cardiovasc Qual Outcomes2011; 4: 496–502.
41.
SchoenenbergerAWStorteckySNeumannSet al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J2013; 34: 684–692.
42.
MuradKKitzmanDW.Frailty and multiple comorbidities in the elderly patient with heart failure: Implications for management. Heart Fail Rev2012; 17: 581–588.
43.
RockwoodKHowlettSEMacKnightCet al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: Report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci2004; 59: 1310–1317.
44.
WoodsNFLaCroixAZGraySLet al. Frailty: Emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc2005; 53: 1321–1330.
45.
RoeMTArmstrongPWFoxKAAet al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med2012; 367: 1297–1309.
46.
VolpatoSCavalieriMSioulisFet al. Predictive value of the Short Physical Performance Battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2011; 66: 89–96.
47.
StorteckySSchoenenbergerAWMoserAet al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv2012; 5: 489–496.
48.
AssmannPKievitPvan der WulpKet al. Frailty is associated with delirium and mortality after transcatheter aortic valve implantation. Open Heart2016; 3: e000478.
49.
LeeDHButhKJMartinBJet al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation2010; 121: 973–978.
50.
KanoSYamamotoMShimuraTet al. Gait speed can predict advanced clinical outcomes in patients who undergo transcatheter aortic valve replacement: Insights from a Japanese multicenter registry. Circ Cardiovasc Interv2017; 25(2): 191–197.
51.
AnandAHarleyCVisvanathanAet al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: A systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes2017; 3: 123–132.
52.
RumsfeldJSMaWhinneySMcCarthyMJret al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA1999; 281: 1298–1303.
53.
SinghMRihalCSRogerVLet al. Comorbid conditions and outcomes after percutaneous coronary intervention. Heart2008; 94: 1424–1428.
54.
SanchezEVidanMTSerraJAet al. Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases. Heart2011; 97: 1602–1606.
55.
SourialNBergmanHKarunananthanSet al. Implementing frailty into clinical practice: A cautionary tale. J Gerontol A Biol Sci Med Sci2013; 68: 1505–1511.
56.
FriedLPFerrucciLDarerJet al. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci2004; 59(3); 255–263.
57.
BraunsteinJBAndersonGFGerstenblithGet al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol2003; 42: 1226–1233.
58.
FultonMMAllenER.Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract2005; 17: 123–132.
59.
ViktilKKBlixHSMogerTAet al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol2007; 63: 187–195.
60.
LarocheMLCharmesJPNouailleYet al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly?Br J Clin Pharmacol2007; 63: 177–186.
61.
O’MahonyDO’SullivanDByrneSet al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Aging2015; 44: 213–218.
62.
BeersMHOuslanderJGRollingherIet al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med1991; 151: 1825–1832.
63.
National Institute for Health and Care Excellence. Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes. Technology appraisal guidance [TA317]. 2014.
64.
AndreottiFRoccaBHustedSet al. Antithrombotic therapy in the elderly: Expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J2015; 36: 3238–3249.
65.
TinettiMEFriedTRBoydCM.Designing health care for the most common chronic condition–multimorbidity. JAMA2012; 307: 2493–2494.
66.
InouyeSKWestendorpRGJSaczynskiJS.Delirium in elderly people. Lancet2013; 383: 911–922.
67.
WitloxJEurelingsLSde JongheJFet al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: A meta-analysis. JAMA2010; 304: 443–451.
68.
NoriegaFJVidanMTSanchezEet al. Incidence and impact of delirium on clinical and functional outcomes in older patients hospitalized for acute cardiac diseases. Am Heart J2015; 170: 938–944.
69.
PauleyELishmanovASchumannSet al. Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit. Am Heart J2015; 170: 79–86.e1.
70.
McPhersonJAWagnerCEBoehmLMet al. Delirium in the cardiovascular ICU: Exploring modifiable risk factors. Crit Care Med2013; 41: 405–413.
71.
PandharipandePPGirardTDJacksonJCet al. Long-term cognitive impairment after critical illness. N Engl J Med2013; 369: 1306–1316.
72.
WeiLAFearingMASternbergEJet al. The Confusion Assessment Method (CAM): A systematic review of current usage. J Am Geriatr Soc2008; 56: 823–830.
73.
VidanMTSanchezEAlonsoMet al. An intervention integrated into daily clinical practice reduces the incidence of delirium during hospitalization in elderly patients. J Am Geriatr Soc2009; 57: 2029–2036.
74.
InouyeSKBogardusSTJCharpentierPAet al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med1999; 340: 669–676.
75.
HanisonJConwayD.A multifaceted approach to prevention of delirium on intensive care. BMJ Qual Improv Rep2015; 4(1): pii: u209656.w4000.
76.
National Institute for Health and Care Excellence. Delirium: Prevention, diagnosis and management. 2010.
77.
NeufeldKJYueJRobinsonTNet al. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: A systematic review and meta-analysis. J Am Geriatr Soc2016; 64: 705–714.
78.
DjaianiGSilvertonNFedorkoLet al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: A randomized controlled trial. Anesthesiology2016; 124: 362–368.
79.
GrahamMMGalbraithPDO’NeillDet al. Frailty and outcome in elderly patients with acute coronary syndrome. Can J Cardiol2013; 29: 1610–1615.
80.
SimmsADBatinPDKurianJet al. Acute coronary syndromes: An old age problem. J Geriatr Cardiol2012; 9: 192–196.
81.
AlabasOAAllanVMcLenachanJMet al. Age-dependent improvements in survival after hospitalisation with acute myocardial infarction: An analysis of the Myocardial Ischemia National Audit Project (MINAP). Age Aging2014; 43: 779–785.
82.
EkerstadNSwahnEJanzonMet al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation2011; 124: 2397–2404.
83.
MyersVDroryYGerberY.Clinical relevance of frailty trajectory post myocardial infarction. Eur J Prev Cardiol2014; 21: 758–766.
84.
KangLZhangSYZhuWLet al. Is frailty associated with short-term outcomes for elderly patients with acute coronary syndrome?J Geriatr Cardiol2015; 12: 662–667.
85.
PurserJLKuchibhatlaMNFillenbaumGGet al. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc2006; 54: 1674–1681.
86.
SanchisJBonanadCRuizVet al. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome. Am Heart J2014; 168: 784–791.
87.
MatsuzawaYKonishiMAkiyamaEet al. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol2013; 61: 1964–1972.
88.
SanchisJNunezERuizVet al. Usefulness of clinical data and biomarkers for the identification of frailty after acute coronary syndromes. Can J Cardiol2015; 31: 1462–1468.
89.
WhiteHDWesterhoutCMAlexanderKPet al. Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Eur Heart J Acute Cardiovasc Care2016; 5: 231–242.
90.
de BoerMJOttervangerJPvan ‘t HofAWet al. Reperfusion therapy in elderly patients with acute myocardial infarction: A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol2002; 39: 1723–1728.
91.
BuenoHBetriuAHerasMet al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J2011; 32: 51–60.
92.
de BoerSPWesterhoutCMSimesRJet al. Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient’s age. JACC Cardiovasc Interv2010; 3: 324–331.
93.
de BoerMJOttervangerJPSuryapranataHet al. Old age and outcome after primary angioplasty for acute myocardial infarction. J Am Geriatr Soc2010; 58: 867–872.
94.
NewellMCHenryJTHenryTDet al. Impact of age on treatment and outcomes in ST-elevation myocardial infarction. Am Heart J2011; 161: 664–672.
95.
GharacholouSMLopesRDAlexanderKPet al. Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: Findings from the APEX-AMI trial. Arch Intern Med2011; 171: 559–567.
96.
FachABungerSZabrockiRet al. Comparison of outcomes of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention analyzed by age groups (<75, 75 to 85, and >85 years); (Results from the Bremen STEMI Registry). Am J Cardiol2015; 116: 1802–1809.
97.
AntonsenLJensenLOTerkelsenCJet al. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: From the Western Denmark Heart Registry. Catheter Cardiovasc Interv2013; 81: 912–919.
98.
KvakkestadKMAbdelnoorMClaussenPAet al. Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study. Eur Heart J Acute Cardiovasc Care2016; 5: 243–252.
99.
ClaessenBEKikkertWJEngstromAEet al. Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: Trends and outcomes. Heart2010; 96: 843–847.
100.
PilgrimTHegDTalKet al. Age- and gender-related disparities in primary percutaneous coronary interventions for acute ST-segment elevation myocardial infarction. PLoS One2015; 10: e0137047.
101.
SoumeraiSBMcLaughlinTJRoss-DegnanDet al. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: Cause for concern in the old-old. Arch Intern Med2002; 162: 561–568.
102.
ArmstrongPWZhengYWesterhoutCMet al. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial. Am Heart J2015; 169: 890–898.e1.
103.
SanchisJNúñezJBodíVet al. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin Proc2011; 86: 291–296.
104.
RoffiMPatronoCColletJPet al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2016; 37: 267–315.
105.
SinclairHKunadianV.Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes. Heart2016; 102: 416–424.
106.
SundermannSDademaschAPraetoriusJet al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg2011; 39: 33–37.
107.
BauerTKoethOJungerCet al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J2007; 28: 2873–2878.
108.
PalauPNunezJSanchisJet al. Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome. Clin Cardiol2012; 35: 237–243.
109.
SavonittoSCavalliniCPetronioASet al. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: A randomized controlled trial. JACC Cardiovasc Interv2012; 5: 906–916.
110.
TegnNAbdelnoorMAabergeLet al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): An open-label randomised controlled trial. Lancet2016; 387: 1057–1065.
111.
SanchisJNunezEBarrabesJAet al. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST-elevation myocardial infarction. Eur J Intern Med2016; 35: 89–94.
112.
BrahmaDKWahlangJBMarakMDet al. Adverse drug reactions in the elderly. J Pharmacol Pharmacother2013; 4: 91–94.
113.
LiamisGMilionisHElisafM.A review of drug-induced hyponatremia. Am J Kidney Dis2008; 52: 144–153.
114.
RoeMTGoodmanSGOhmanEMet al. Elderly patients with acute coronary syndromes managed without revascularization: Insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel. Circulation2013; 128: 823–833.
115.
ChewDPJunboGParsonageWet al. Perceived risk of ischemic and bleeding events in acute coronary syndromes. Circ Cardiovasc Qual Outcomes2013; 6: 299–308.
116.
QaderdanKIshakMHeestermansAAet al. Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older–rationale and design of the POPular AGE study. Am Heart J2015; 170: 981–985.e1.
VidánMTSánchezEFernández-AvilésFet al. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: Rationale, methods and baseline characteristics. Clin Cardiol2014; 37: 725–732.
119.
VidanMTBlaya-NovakovaVSanchezEet al. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail2016; 18: 869–875.
120.
ReevesGRWhellanDJPatelMJet al. Comparison of frequency of frailty and severely impaired physical function in patients >/=60 years hospitalized with acute decompensated heart failure versus chronic stable heart failure with reduced and preserved left ventricular ejection fraction. Am J Cardiol2016; 117: 1953–1958.
121.
VolpatoSCavalieriMGuerraGet al. Performance-based functional assessment in older hospitalized patients: Feasibility and clinical correlates. J Gerontol A Biol Sci Med Sci2008; 63: 1393–1398.
122.
SternbergSAWershof SchwartzAKarunananthanSet al. The identification of frailty: A systematic literature review. J Am Geriatr Soc2011; 59: 2129–2138.
123.
Rodríguez-MañasLFéartCMannGet al. Searching for an operational definition of frailty: A Delphi Method based consensus statement. The Frailty Operative Definition-Consensus Conference Project. J Gerontol A Biol Sci Med Sci2013; 68: 62–67.
124.
MiroOPeacockFWMcMurrayJJet al. European Society of Cardiology – Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. Eur Heart J Acute Cardiovasc Care2017; 6: 311–320.
125.
AfilaloJEisenbergMJMorinJFet al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol2010; 56: 1668–1676.
126.
AfilaloJMottilloSEisenbergMJet al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes2012; 5: 222–228.
127.
EweSHAjmone MarsanNPepiMet al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J2010; 160: 1113–1120.
128.
GreenPWoglomAEGenereuxPet al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience. JACC Cardiovasc Interv2012; 5: 974–981.
129.
SepehriABeggsTHassanAet al. The impact of frailty on outcomes after cardiac surgery: A systematic review. J Thorac Cardiovasc Surg2014; 148: 3110–3117.
130.
Dominguez-RodriguezAAbreu-GonzalezPJimenez-SosaAet al. The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator. Europace2015; 17: 598–602.
131.
PilottoAAddanteFFranceschiMet al. Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 2010; 3: 14–20.
132.
Rodriguez-PascualCParedes-GalanEVilches-MoragaAet al. Comprehensive geriatric assessment and 2-year mortality in elderly patients hospitalized for heart failure. Circ Cardiovasc Qual Outcomes2014; 7: 251–258.
133.
UchmanowiczIWleklikMGobbensRJ.Frailty syndrome and self-care ability in elderly patients with heart failure. Clin Interv Aging2015; 10: 871–877.
134.
HiiTBLainchburyJGBridgmanPG.Frailty in acute cardiology: Comparison of a quick clinical assessment against a validated frailty assessment tool. Heart Lung Circ2015; 24: 551–556.
135.
Martín-SánchezFJRodríguez-AdradaEMuellerCet al. The effect of frailty on 30-day mortality risk in older patients with acute heart failure attended in the emergency department. Acad Emerg Med2017; 24: 298–307.
136.
Zoni-BerissoMLercariFCarazzaTet al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol2014; 6: 213–220.
137.
LipGYClementyNPericartLet al. Stroke and major bleeding risk in elderly patients aged >/=75 years with atrial fibrillation: The Loire Valley atrial fibrillation project. Stroke2015; 46: 143–150.
138.
LipGYLaneDA.Bleeding risk assessment in atrial fibrillation: Observations on the use and misuse of bleeding risk scores. J Thromb Haemost2016; 14(9): 1711–1714.
139.
FreedmanBPotparaTSLipGY.Stroke prevention in atrial fibrillation. Lancet2016; 388: 806–817.
140.
LipGYHLaneD. Stroke prevention in atrial fibrillation. A systematic review. JAMA2015; 313: 1950–1962.
141.
DonzeJClairCHugBet al. Risk of falls and major bleeds in patients on oral anticoagulation therapy. Am J Med2012; 125: 773–778.
142.
BanerjeeAClementyNHaguenoerKet al. Prior history of falls and risk of outcomes in atrial fibrillation: The Loire Valley Atrial Fibrillation Project. Am J Med2014; 127: 972–978.
143.
BajorekBVKrassIOgleSJet al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention. J Am Geriatr Soc2005; 53: 1912–1920.
144.
PereraVBajorekBVMatthewsSet al. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Aging2009; 38: 156–162.
145.
LefebvreMCSt-OngeMGlazer-CavanaghMet al. The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: The FRAIL-AF Study. Can J Cardiol2016; 32: 169–176.
146.
TulnerLRVan CampenJPKuperIMet al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: A prospective, descriptive study. Drugs Aging2010; 27: 39–50.
147.
CowanCHealiconRRobsonIet al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart2013; 99: 1166–1172.
148.
MantJHobbsFDFletcherKet al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet2007; 370: 493–503.
149.
ConnollySJEikelboomJJoynerCet al. Apixaban in patients with atrial fibrillation. N Engl J Med2011; 364: 806–817.
150.
RashADownesTPortnerRet al. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Aging2007; 36: 151–156.
151.
LaneDALipGY.Patient’s values and preferences for stroke prevention in atrial fibrillation: Balancing stroke and bleeding risk with oral anticoagulation. Thromb Haemost2014; 111: 381–383.
152.
LahayeSRegpalaSLacombeSet al. Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost2014; 111: 465–473.
153.
LaneDAAguinagaLBlomstrom-LundqvistCet al. Cardiac tachyarrhythmias and patient values and preferences for their management: The European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace2015; 17(12): 1747–1769.
National Institute for Health and Care Excellence. Atrial fibrillation: The management of atrial fibrillation (Clinical guideline 180), http://guidance.nice.org.uk/CG180 (2014).
156.
KirchhofPBenussiSKotechaDet al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC endorsed by the European Stroke Organisation (ESO). Europace2016; 8(11): 1609–1678.
157.
MlynarskaAMlynarskiRGolbaKS.Influence of frailty on the quality of life patients qualified for pacemaker implantation. J Clin Nurs. Epub ahead of print 25May2017. DOI: 10.1111/jocn.13897.
158.
ManianUGulaLJ.Arrhythmia management in the elderly-implanted cardioverter defibrillators and prevention of sudden death. Can J Cardiol2016; 32: 1117–1123.
159.
GoonewardeneMBarraSHeckPet al. Cardioverter-defibrillator implantation and generator replacement in the octogenarian. Europace2015; 17: 409–416.
160.
AngusDCBarnatoAELinde-ZwirbleWTet al. Use of intensive care at the end of life in the United States: An epidemiologic study. Crit Care Med2004; 32: 638–643.
161.
BagshawSMWebbSADelaneyAet al. Very old patients admitted to intensive care in Australia and New Zealand: A multi-centre cohort analysis. Crit Care2009; 13(2): R45.
162.
SprungCLBarasMIapichinoGet al. The Eldicus prospective, observational study of triage decision making in European intensive care units: Part I–European Intensive Care Admission Triage Scores. Crit Care Med2012; 40: 125–131.
163.
SprungCLArtigasAKeseciogluJet al. The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly. Crit Care Med2012; 40(1): 132–138.
164.
Le MaguetPRoquillyALasockiSet al. Prevalence and impact of frailty on mortality in elderly ICU patients: A prospective, multicenter, observational study. Intensive Care Med2014; 40: 674–682.
165.
UnroeMKahnJMCarsonSSet al. One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: A cohort study. Ann Intern Med2010; 153: 167–175.
166.
CharlsonMEHollenbergJPHouJet al. Realizing the potential of clinical judgment: A real-time strategy for predicting outcomes and cost for medical inpatients. Am J Med2000; 109: 189–195.
167.
ChanDCTsouHHChenCY.Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version. Arch Gerontol Geriatr2010; 50(3): e74–80.
168.
BaldwinMRReidMCWestlakeAAet al. The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors. J Crit Care2014; 29: 401–408.
169.
WinkelmanC.The role of inflammation in ICU-acquired weakness. Crit Care2010; 14(4): 186.
170.
CharlesBPorterRBrydenD.Feasibility and utility of frailty assessment in the over 80 s on critical care. Crit Care2011; 15(Suppl 1): P499.
171.
MasudDNortonSSmailesSet al. The use of a frailty scoring system for burns in the elderly. Burns2013; 39: 30–36.
172.
BagshawSMStelfoxHTMcDermidRCet al. Association between frailty and short- and long-term outcomes among critically ill patients: A multicentre prospective cohort study. CMAJ2014; 186: E95–E102.
173.
FisherCKaralapillaiDKBaileyMet al. Predicting intensive care and hospital outcome with the Dalhousie Clinical Frailty Scale: A pilot assessment. Anaesth Intensive Care2015; 43: 361–368.
174.
BagshawSMStelfoxHTJohnsonJAet al. Long-term association between frailty and health-related quality of life among survivors of critical illness: A prospective multicenter cohort study. Crit Care Med2015; 43: 973–982.
175.
ZengASongXDongJet al. Mortality in relation to frailty in patients admitted to a specialized geriatric intensive care unit. J Gerontol A Biol Sci Med Sci2015; 70: 1586–1594.
